STOCK TITAN

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) Financials

VYLD NYSE
Trailing 12 months to September 30, 2026
Revenue $203.2B +13.2% YoY
Net Income $66.0B +13.7% YoY
EPS (Diluted) $23.85 +18.1% YoY
Operating Cash Flow -$84.2B n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VYLD SEC filings page.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) reported $203.2B in revenue over the twelve months to Sep 30, 2026, up 13.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VYLD FY2025

The reported scale expanded sharply in FY2025, while liabilities funded more of that growth than equity, fitting a market-linked note structure.

Balance-sheet expansion became more liability-funded: from FY2023 to FY2025, assets increased 14.2% while liabilities rose 14.5% and equity grew 10.5%. That divergence matters more here than operating margins because an ETN’s reported statements primarily reflect the note’s financial structure and market-linked accounting outcomes.

The reported FY2025 net income was $57.0B, down 2.4% even as reported revenue reached $182.4B, up 2.8%. For an ETN, that combination should not be interpreted like slowing sales or weakening product margins; it describes reported accounting results rather than a conventional operating engine.

Liabilities represented 91.8% of FY2025 assets, with total liabilities of $4.1T against $362.4B of equity. The large liability base is therefore a central feature of the reported instrument structure, not a useful indicator of ordinary corporate operating leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Inverse VIX Short-Term Futures ETNs due March 22, 2045, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/6

Inverse VIX Short-Term Futures ETNs due March 22, 2045 passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Inverse VIX Short-Term Futures ETNs due March 22, 2045 used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$50.2B
YoY+8.1%
QoQ-12.5%
5Y CAGR+11.1%
10Y CAGR+7.4%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 generated $50.2B in revenue in Q3 2026. This represents an increase of 8.1% from the same quarter a year earlier. Against the prior quarter it is down 12.5%.

Net Income
$15.3B
YoY+6.3%
QoQ-27.7%
5Y CAGR+5.5%
10Y CAGR+9.3%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 reported $15.3B in net income in Q3 2026. This represents an increase of 6.3% from the same quarter a year earlier. Against the prior quarter it is down 27.7%.

EPS (Diluted)
$5.57
YoY+9.9%
QoQ-27.7%
5Y CAGR+8.3%
10Y CAGR+13.4%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 earned $5.57 per diluted share (EPS) in Q3 2026. This represents an increase of 9.9% from the same quarter a year earlier. Against the prior quarter it is down 27.7%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$326.3B
YoY+7.5%
QoQ+5.3%
5Y CAGR-15.6%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 held $326.3B in cash as of Q3 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$1.65
YoY+10.0%
QoQ+10.0%
5Y CAGR+10.5%
10Y CAGR+13.1%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 paid $1.65 per share in dividends in Q3 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is up 10.0%.

Shares Outstanding
2.66B
YoY-2.4%
QoQ-0.1%
5Y CAGR-2.1%
10Y CAGR-2.9%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 had 2.66B shares outstanding in Q3 2026. This represents a decrease of 2.4% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Free Cash Flow

Not reported for Q3 2026.

Margins & Returns

Net Margin
30.5%
YoY-0.5pp
QoQ-6.4pp
5Y change-8.9pp
10Y change+5.0pp

Inverse VIX Short-Term Futures ETNs due March 22, 2045's net profit margin was 30.5% in Q3 2026, showing the share of revenue converted to profit. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.4 percentage points.

Return on Equity
4.1%
YoY+0.1pp
QoQ-1.5pp
5Y change+0.1pp
10Y change+1.6pp

Inverse VIX Short-Term Futures ETNs due March 22, 2045's quarterly ROE was 4.1% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$1.1B
YoY-86.6%
QoQ-83.7%
5Y CAGR-26.8%

Inverse VIX Short-Term Futures ETNs due March 22, 2045 spent $1.1B on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 86.6% from the same quarter a year earlier. Against the prior quarter it is down 83.7%.

R&D Spending

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

VYLD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VYLD quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$50.2B+8.1%$57.3B+27.7%$49.8B+10.0%$45.8B+7.1%$46.4B+8.8%$44.9B-10.5%$45.3B+8.1%$42.8B+10.9%
Interest Expense$26.0B+2.1%$25.1B+0.3%$23.8B+1.0%$23.8B-1.7%$25.5B-5.7%$25.0B-2.9%$23.6B-3.2%$24.2B+3.8%
Income Tax$4.8B+11.0%$6.4B+92.9%$4.0B+5.8%$4.1B+22.7%$4.3B+6.6%$3.3B-37.6%$3.8B-2.8%$3.4B+66.9%
Net Income$15.3B+6.3%$21.2B+41.2%$16.5B+12.6%$13.0B-7.0%$14.4B+11.6%$15.0B-17.4%$14.6B+9.1%$14.0B+50.5%
EPS (Basic)$5.58+9.8%$7.71+46.9%$5.95+17.1%$4.64-3.7%$5.08+16.0%$5.25-14.4%$5.08+14.2%$4.82+58.0%
EPS (Diluted)$5.57+9.9%$7.70+46.9%$5.94+17.2%$4.64-3.5%$5.07+16.0%$5.24-14.4%$5.07+14.2%$4.81+57.7%
Diluted Shares (Avg)2.68B-3.1%2.69B-3.6%2.72B-3.7%N/A2.77B-3.4%2.79B-3.5%2.82B-3.0%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

VYLD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VYLD quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$5.1T+11.7%$5.0T+10.2%$4.9T+12.5%$4.4T+10.5%$4.6T+8.3%$4.6T+9.9%$4.4T+6.5%$4.0T+3.3%
Cash & Equivalents$326.3B+7.5%$309.8B-26.3%$312.1B-26.7%$343.3B-26.8%$303.4B-30.1%$420.3B-20.8%$425.9B-24.2%$469.3B-24.8%
Goodwill$52.7B0.0%$52.7B-0.1%$52.7B+0.2%$52.7B+0.3%$52.7B0.0%$52.7B+0.2%$52.6B0.0%$52.6B-0.1%
Total Liabilities$4.7T+12.4%$4.6T+10.6%$4.5T+13.2%$4.1T+11.1%$4.2T+8.7%$4.2T+10.3%$4.0T+6.7%$3.7T+3.1%
Total Equity$372.4B+3.4%$374.6B+5.0%$364.0B+3.6%$362.4B+5.1%$360.2B+4.2%$356.9B+4.8%$351.4B+4.4%$344.8B+5.1%
Retained Earnings$455.6B+11.8%$445.0B+12.0%$428.2B+10.8%$416.1B+10.6%$407.4B+11.3%$397.4B+11.3%$386.6B+12.9%$376.2B+13.0%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

VYLD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VYLD quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$33.2Bn/m-$25.3B-185.6%-$211.8Bn/m$119.7B-19.0%-$45.2Bn/m$29.5B-23.2%-$251.8Bn/m$147.8B+145.3%
Depreciation & Amortization$2.9B+27.9%$2.3B+4.8%$2.4B+16.5%$2.3B+17.7%$2.3B+15.4%$2.2B+10.4%$2.0B+1.3%$2.0B-41.1%
Stock-Based Compensation$1.1B+21.5%$1.2B+21.7%$1.2B+11.4%N/A$910.0M+7.2%$959.0M+1.6%$1.1B+12.3%N/A
Investing Cash Flow-$90.1Bn/m$6.4Bn/m-$217.8Bn/m$46.9B+166.1%-$21.3Bn/m-$173.1Bn/m-$118.1Bn/m$17.6B-77.9%
Financing Cash Flow$72.5Bn/m$18.8B-84.7%$400.7B+26.0%-$123.6Bn/m-$47.8B-544.6%$122.8B+350.9%$318.1B+125.3%-$115.7Bn/m
Dividends Paid$4.3B+3.4%$4.3B+3.3%$4.4B+14.4%$4.4B+14.5%$4.2B+14.4%$4.2B+11.3%$3.8B+9.4%$3.9B+12.6%
Share Buybacks$1.1B-86.6%$6.8B-9.6%$8.3B+10.6%$8.3B+92.1%$8.3B+30.4%$7.5B+40.7%$7.5B+165.8%$4.3B+89.1%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

VYLD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VYLD quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin30.5%-0.5pp36.9%+3.5pp33.1%+0.8pp28.4%-4.3pp31.0%+0.8pp33.4%-2.8pp32.3%+0.3pp32.8%+8.6pp
Return on Equity4.1%+0.1pp5.7%+1.4pp4.5%+0.4pp3.6%-0.5pp4.0%+0.3pp4.2%-1.1pp4.2%+0.2pp4.1%+1.2pp
Return on Assets0.3%0.0pp0.4%+0.1pp0.3%0.0pp0.3%-0.1pp0.3%0.0pp0.3%-0.1pp0.3%0.0pp0.4%+0.1pp
Liabilities-to-Equity12.67+1.0x12.39+0.6x12.46+1.1x11.21+0.6x11.66+0.5x11.75+0.6x11.40+0.2x10.61-0.2x
Asset Turnover0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.

Frequently Asked Questions

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) reported $182.4B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) revenue grew by 2.8% year-over-year, from $177.6B to $182.4B in fiscal year 2025.

Yes, Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) reported a net income of $66.0B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $57.0B, with a net profit margin of 31.3%.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) reported diluted earnings per share of $20.02 for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) had a net profit margin of 31.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) paid $5.80 per share in dividends during fiscal year 2025.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) has a return on equity of 15.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) recorded an outflow of $147.8B in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) had $4.4T in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) spent $31.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) had 2.70B shares outstanding as of fiscal year 2025.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) had a liabilities-to-equity ratio of 11.21 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top